tiprankstipranks
Gilead Sciences (MX:GILD)
:GILD
Mexico Market
GILD
Gilead Sciences
RESEARCH TOOLSreports

Gilead Sciences (GILD) Income Statement

0 Followers

Gilead Sciences Income Statement

Last quarter (Q2 2026), Gilead Sciences's total revenue was $7.80B, an increase of 10.20% from the same quarter last year. In Q2, Gilead Sciences's net income was $-10.50B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 29.44B$ 28.75B$ 27.12B$ 27.28B$ 27.30B
Gross Profit
$ 23.21B$ 22.50B$ 20.62B$ 21.62B$ 20.70B
Operating Expenses
$ 11.51B$ 20.84B$ 13.01B$ 14.29B$ 10.79B
Depreciation and Amortization
$ 2.76B$ 2.77B$ 2.69B$ 2.10B$ 2.05B
EBITDA
$ 13.58B$ 4.43B$ 10.50B$ 8.85B$ 11.33B
Operating Income
$ 11.70B$ 1.66B$ 7.61B$ 7.33B$ 9.92B
Other Income/Expenses
$ -1.91B$ -972.00M$ -746.00M$ -1.52B$ -1.64B
Pretax Income
$ 9.80B$ 690.00M$ 6.86B$ 5.81B$ 8.28B
Net Income
$ 8.51B$ 480.00M$ 5.67B$ 4.59B$ 6.22B
Per Share Metrics
Basic EPS
$ 6.84$ 0.38$ 4.54$ 3.66$ 4.96
Diluted EPS
$ 6.78$ 0.38$ 4.50$ 3.64$ 4.93
Weighted Average Shares Outstanding
 1.24B 1.25B 1.25B 1.25B 1.26B
Weighted Average Shares Outstanding (Diluted)
 1.25B 1.25B 1.26B 1.26B 1.26B
Currency in USD

Gilead Sciences Earnings and Revenue History